Multiple sclerosis – new therapeutic directions

Łowiec, Paweł; Trzonkowski, Piotr; Chwojnicki, Kamil

Multiple sclerosis – new therapeutic directions

dc.contributor.author	Łowiec, Paweł
dc.contributor.author	Trzonkowski, Piotr
dc.contributor.author	Chwojnicki, Kamil
dc.contributor.organization	Gdański Uniwersytet Medyczny	en
dc.date.accessioned	2019-08-27T10:04:37Z
dc.date.available	2019-08-27T10:04:37Z
dc.date.issued	2019
dc.description.abstract	Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease which affects the central nervous system. Currently, there are numerous disease-modifying therapies for this condition. Most of them address the inflammatory aspects of the disease and are most effective in the relapsing-remitting stages of multiple sclerosis. However, none of them can completely stop the progression of MS and they are usually associated with adverse effects. There is an ongoing search for novel approaches that involve different modes of action. Here, we discuss examples of new immunomodulating agents such as antigen-specific therapies, neuroprotectants, regenerative strategies and gut microbiota modification.	en
dc.identifier.citation	Łowiec P, Trzonkowski P, Chwojnicki K. Multiple sclerosis – new therapeutic directions. Eur J Transl Clin Med. 2019;2(1):7-22. DOI: 10.31373/ejtcm/109612	en
dc.identifier.issn	2657-3156
dc.identifier.uri	https://open.icm.edu.pl/handle/123456789/17241
dc.language.iso	en
dc.publisher	Gdański Uniwersytet Medyczny	en
dc.rights	Uznanie autorstwa-Na tych samych warunkach 3.0 Polska	*
dc.rights.uri	http://creativecommons.org/licenses/by-sa/3.0/pl/	*
dc.subject	multiple sclerosis	en
dc.subject	neuroprotection	en
dc.subject	novel therapies	en
dc.subject	remyelination	en
dc.subject	gut microbiome	en
dc.title	Multiple sclerosis – new therapeutic directions	en
dc.type	article	en